omega3 PUFA add-on therapy for bipolar disorder: genotype stratified analysis
Phase 2
- Conditions
- Bipolar disorder
- Registration Number
- JPRN-jRCTs041180075
- Lead Sponsor
- Iwata Nakao
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Bipolar Disorder (I and II) diagnosed by DSM-V
Exclusion Criteria
Bipolar disorder (rapid cycling) diagnosed by DSM-V
patients who are taking EPA/DHA
Allergy for EPA DHA
metabolic syndrome at the enrollment
side effect by EPA DHA
high risk of hemorrhage
patients who received more than 3 types of antipsychotics
patients who received more than 3 types of antidepressants (exclude antidepressants which use only as hypnotics)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method